A faulty version of Fig. 1 was submitted for publication. The corrected figure is reproduced here.
Workflow of the proteomic analysis applied to tissue and urine samples. Left panel Kidney sub-compartments (i.e. glomeruli, tubuli, etc.) can be isolated from whole biopsy specimens through laser capture microdissection (LCM) prior to performing proteomic analysis. Alternatively, frozen or formalin fixed and paraffin embedded (FFPE) tissues can be directly analysed by matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS). Right panel Ultracentrifugation of whole urine samples is used to separate soluble and vesicular fractions, then proteomic analysis may allow the identification of compartment-specific biomarkers. The bioinformatic management of urine and tissue putative biomarkers is then applied to each dataset in order to select functionally correlated disease biomarkers [72] . Comparative analysis may finally allow to identify tissue-derived biomarkers also detectable in the urine samples. LCM glomeruli and MALDI-IMS figures are reproduced with permission from Kohda et al. [73] and Chaurand et al. [74] , respectively
